Biotech Hangout
by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 35 chart positions in 35 markets.
By chart position
- 🇺🇸US · Life Sciences#20300K to 1M
- 🇨🇦CA · Life Sciences#31100K to 300K
- 🇬🇧GB · Life Sciences#37100K to 300K
- 🇦🇺AU · Life Sciences#39100K to 300K
- 🇩🇪DE · Life Sciences#8030K to 100K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
525K to 1.7M🎙 ~2x weekly·148 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
1.0M to 3.3M🇺🇸30%🇨🇦9%🇬🇧9%+32 more - Active Followers
Loyal subscribers who consistently listen
315K to 1.0M
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 19 epsHosts
Recent guests
Recent episodes
Episode 189 - July 17, 2026
Jul 17, 2026
58m 16s
Episode 188 - July 10, 2026
Jul 10, 2026
1h 00m 52s
Episode 187 - June 26, 2026
Jun 26, 2026
1h 00m 06s
Episode 186 - June 12, 2026
Jun 12, 2026
1h 01m 29s
Episode 185 -June 5, 2026
Jun 9, 2026
1h 00m 28s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/17/26 | biotech market volatilitypharma business+5 | Yaron WerberJohn Maraganore+2 | Lipfendrasunvozertinib+12 | — | biotechEli Lilly+7 | — | 58m 16s | ||
| 7/10/26 | biotech marketFDA transparency+3 | Sam FazeliEric Schmidt+2 | mitapivatMyricx+14 | — | biotechFDA+5 | — | 1h 00m 52s | ||
| 6/26/26 | biotech industryacquisitions+3 | Eric SchmidtTess Cameron+1 | AbbVieApogee+7 | — | biotechacquisition+5 | — | 1h 00m 06s | ||
| 6/12/26 | biotech marketIPO activity+4 | Graig SuvannavejhEric Schmidt+2 | Financial TimesSonoThera+18 | China | biotechIPO+5 | — | 1h 01m 29s | ||
| 6/9/26 | biotech market trendspolicy and regulation+4 | Yaron WerberTess Cameron+2 | ivonescimabKRAS+7 | — | biotechAI+5 | — | 1h 00m 28s | ||
| 5/29/26 | biopharma market updategenetic engineering+4 | Jason Kelly | Ginkgo BioworksEndpoints+9 | — | biopharmaIPO+5 | — | 58m 11s | ||
| 5/15/26 | drug developmentChina outsourcing+5 | Sam FazeliEric Schmidt+1 | HengruiBMS+6 | — | HengruiBMS+8 | — | 1h 01m 20s | ||
| 5/8/26 | biotech newsM&A activity+3 | Allison DeAngelis | teplizumabCytokinetics+15 | — | biotechM&A+3 | — | 1h 00m 15s | ||
| 5/8/26 | biotech public-market dynamicsIPO window reopening+5 | Eric SchmidtMatt Gline+3 | XBILilly+3 | — | biotechIPO+5 | — | 1h 00m 02s | ||
| 4/17/26 | public marketsbiotech sector+4 | Chris CarabedianPaul Matteis+2 | XBIKailera+9 | — | biotechIPO+7 | — | 53m 48s | ||
| 4/10/26 | biotech sectorpublic markets+4 | Greg SuvannavejhYaron Werber+2 | Financial TimesTrump administration+16 | — | biotechpublic markets+6 | — | 59m 55s | ||
| 4/3/26 | biotech deal activityM&A environment+4 | Graig SuvannavejhMike Yee+1 | GLP-1NLRP3 inhibitors+10 | — | biotechM&A+5 | — | 1h 00m 44s | ||
| 3/27/26 | biotechmarket volatility+3 | Grace ColónEric Schmidt+1 | AvlayahGilead+14 | — | biotechmarket volatility+3 | — | 55m 53s | ||
| 3/13/26 | biotech investor sentimentgeopolitics+5 | Sam FazeliPaul Matteis+1 | FDAGenentech+9 | — | biotechFDA+5 | — | 1h 00m 32s | ||
| 3/6/26 | market volatilitycapital markets+5 | Mike YeeEric Schmidt+2 | GLP-1Roivant+3 | Miami | biotechmarket volatility+7 | — | 52m 16s | ||
| 2/27/26 | regulatory updatesbiotech acquisitions+3 | Tess CameronAdam Feuerstein | Ebvalloanito-cel+15 | — | FDAbiotech+3 | — | 57m 39s | ||
| 2/20/26 | drug developmentbiotech outlook+5 | Eric SchmidtPaul Matteis+3 | FDAModerna+4 | — | biotechFDA+8 | — | 59m 50s | ||
| 2/6/26 | biotech IPOsFDA policy+4 | Graig SuvannavejhChris Garabedian+2 | VeradermicsEikon Therapeutics+10 | — | biotechIPO+6 | — | 59m 08s | ||
| 1/30/26 | biotech policyFDA updates+4 | John Crowley | BIOFDA+5 | — | biotech raceFDA+7 | — | 59m 25s |
Showing 19 of 19
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Biotech Hangout
Peaked at #3 in HK, top 10 in 1 of 39 tracked markets, currently #3 in HK.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| HK | — | #3 | #3 | — |
| CZ | — | #16 | #16 | — |
| SG | — | #18 | #18 | — |
| United States | — | #20 | #20 | — |
| GR | — | #20 | #20 | — |
| CH | — | #21 | #21 | — |
| HK | — | #21 | #21 | — |
| Ireland | — | #25 | #25 | — |
| New Zealand | — | #25 | #25 | — |
| MY | — | #29 | #29 | — |
| Canada | — | #31 | #31 | — |
| AT | — | #31 | #31 | — |
| IL | — | #31 | #31 | — |
| TW | — | #31 | #31 | — |
| BE | — | #36 | #36 | — |
| South Korea | — | #36 | #36 | — |
| United Kingdom | — | #37 | #37 | — |
| Australia | — | #39 | #39 | — |
| PL | — | #41 | #41 | — |
| Japan | — | #44 | #44 | — |
Chart Positions
39 placements across 35 markets.
Chart Positions
39 placements across 35 markets.